Connect your AI

Opus Genetics IRD Convertible Debt - Current

Convertible Debt - Current at other companies

BillionToOne, Inc. BLLN

$0-100%

Ondas, Inc. ONDS

$10M+400%

Empire State Realty TrustESRT

$1.27B+15.8%

MannkindMNKD

$36.28M—

Bit DigitalBTBT

$150M—

ImaxIMAX

$244.13M+6.1%

Other financials

Income statement

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

Operating cash flow-$12.7M-41.5%

Valuation

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:TemporaryEquityCarryingAmountAttributableToParent.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's convertible debt - current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Opus Genetics's convertible debt - current?: Opus Genetics (IRD) reported convertible debt - current of $24.74M in Q1 2026.